Significantly higher HMGB1, LRP, MRP, P-gp, and Bcl-2 expression levels while lower Bax expression were observed in recurrence NSCLC samples compared to pre-operation NSCLC samples (Fig. 1h and i). The gene discussed is HMGB1; the disease is non-small cell lung carcinoma.